Idera Pharmaceuticals Inc. (IDRA) Soars 2.86% on May 20

Equities Staff  |

Idera Pharmaceuticals Inc. (IDRA) had a good day on the market for Wednesday May 20 as shares jumped 2.86% to close at $1.80. About 63,639 shares traded hands on 474 trades for the day, compared with an average daily volume of n/a shares out of a total float of 33.7 million. After opening the trading day at $1.75, shares of Idera Pharmaceuticals Inc. stayed within a range of $1.81 to $1.74.

With today's gains, Idera Pharmaceuticals Inc. now has a market cap of $60.67 million. Shares of Idera Pharmaceuticals Inc. have been trading within a range of $3.58 and $0.82 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases. The company has developed two distinct proprietary drug-discovery technology platforms: Toll-like receptor and third-generation antisense technology. The Toll-like receptor technology helped the company create synthetic oligonucleotide-based drug candidates.

Idera Pharmaceuticals Inc. is based out of Exton, PA and has some 36 employees. Its CEO is Vincent J. Milano.

For a complete fundamental analysis of Idera Pharmaceuticals Inc., check out’s Stock Valuation Analysis report for IDRA.

Still paying commissions on stock trades? now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by

Idera Pharmaceuticals Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Idera Pharmaceuticals Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: IDRA’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change